• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerations.

作者信息

Barton Greg, Rickard Claire M, Roberts Jason A

机构信息

Pharmacy Department, Whiston Hospital, Mersey and West Lancashire Teaching Hospital NHS Trust, Rainhill, UK.

The University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Butterfield St, Herston, Risbane, Australia.

出版信息

Intensive Care Med. 2024 Dec;50(12):2150-2153. doi: 10.1007/s00134-024-07650-x. Epub 2024 Sep 23.

DOI:10.1007/s00134-024-07650-x
PMID:39311902
Abstract
摘要

相似文献

1
Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerations.在脓毒症重症患者中持续输注β-内酰胺类抗生素：实施要点
Intensive Care Med. 2024 Dec;50(12):2150-2153. doi: 10.1007/s00134-024-07650-x. Epub 2024 Sep 23.
2
A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.一项关于脓毒症重症患者连续与间歇β-内酰胺类抗生素输注的3期多中心随机对照试验方案：BLING III
Crit Care Resusc. 2019 Mar;21(1):63-68.
3
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.严重脓毒症的β-内酰胺输注（BLISS）：一项前瞻性、双中心、开放标签随机对照试验，比较了连续性与间歇性β-内酰胺输注在重症严重脓毒症患者中的应用。
Intensive Care Med. 2016 Oct;42(10):1535-1545. doi: 10.1007/s00134-015-4188-0. Epub 2016 Jan 11.
4
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.严重脓毒症中连续与间断β-内酰胺输注的比较。来自随机试验的个体患者数据的荟萃分析。
Am J Respir Crit Care Med. 2016 Sep 15;194(6):681-91. doi: 10.1164/rccm.201601-0024OC.
5
A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.一项多中心随机对照试验方案，比较连续β-内酰胺输注与重症脓毒症患者间歇性β-内酰胺给药：BLING II 研究。
Crit Care Resusc. 2013 Sep;15(3):179-85.
6
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.连续与间断β-内酰胺类抗生素输注治疗脓毒症危重症患者的比较：BLING III 随机临床试验。
JAMA. 2024 Aug 27;332(8):629-637. doi: 10.1001/jama.2024.9779.
7
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.β-内酰胺类抗生素在成人脓毒症或感染性休克中持续输注与间断输注的比较：系统评价和荟萃分析。
JAMA. 2024 Aug 27;332(8):638-648. doi: 10.1001/jama.2024.9803.
8
Should β-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists.β-内酰胺类抗生素是否应在危重症患者中持续输注？对澳大利亚和新西兰重症监护病房医生和药剂师的调查。
Int J Antimicrob Agents. 2016 Jun;47(6):436-8. doi: 10.1016/j.ijantimicag.2016.02.017. Epub 2016 Apr 25.
9
Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.与危重症患者β-内酰胺类抗生素临床应用相关的药代动力学-药效学问题。
Crit Care. 2018 Sep 24;22(1):233. doi: 10.1186/s13054-018-2155-1.
10
Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial.脓毒症重症患者中β-内酰胺类抗生素标准剂量与双倍剂量对比研究：一项多中心随机对照试验的BULLSEYE研究方案
BMC Infect Dis. 2025 Mar 21;25(1):392. doi: 10.1186/s12879-025-10747-3.

引用本文的文献

1
Enough is Enough: Continuous Beta-Lactam Infusions for Treating Serious Infections.适可而止：持续β-内酰胺类药物输注治疗严重感染
J Assoc Med Microbiol Infect Dis Can. 2024 Dec 19;9(4):200-203. doi: 10.3138/jammi-2024-1104. eCollection 2024 Dec.
2
Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024.迈向肺部感染的整体治疗方法。来自2024年西班牙专家第六届年会的见解。
Rev Esp Quimioter. 2025 Mar 27;38(3):152-186. doi: 10.37201/req/017.2025.
3
Include environmental sustainability in clinical trial design and implementation strategies: the BLING-III trial as an illustrative example.

本文引用的文献

1
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.β-内酰胺类抗生素在成人脓毒症或感染性休克中持续输注与间断输注的比较：系统评价和荟萃分析。
JAMA. 2024 Aug 27;332(8):638-648. doi: 10.1001/jama.2024.9803.
2
Infusion Therapy Standards of Practice, 9th Edition.《输液治疗实践标准》第9版
J Infus Nurs. 2024;47(1S Suppl 1):S1-S285. doi: 10.1097/NAN.0000000000000532.
3
Risk factors associated with catheter-related venous thrombosis: a meta-analysis.与导管相关的静脉血栓形成的相关危险因素：一项荟萃分析。
将环境可持续性纳入临床试验设计和实施策略：以BLING-III试验为例。
Intensive Care Med. 2025 Feb;51(2):440-441. doi: 10.1007/s00134-024-07763-3. Epub 2024 Dec 23.
4
Beta-lactam administration, which one is the best for the planet?β-内酰胺类药物的使用，哪一种对地球最为有利？
Intensive Care Med. 2025 Jan;51(1):224-227. doi: 10.1007/s00134-024-07697-w. Epub 2024 Dec 12.
5
Considerations for β-lactam antimicrobial continuous infusion. Authors' reply to Massart et al. and Marzaroli et al.β-内酰胺类抗菌药物持续输注的考量。作者对马萨特等人及马尔扎罗利等人的回复
Intensive Care Med. 2025 Jan;51(1):230-231. doi: 10.1007/s00134-024-07724-w. Epub 2024 Dec 12.
6
Optimizing meropenem infusion: the importance of concentration and stability.优化美罗培南输注：浓度和稳定性的重要性。
Intensive Care Med. 2025 Jan;51(1):228-229. doi: 10.1007/s00134-024-07709-9. Epub 2024 Nov 4.
Public Health. 2022 Apr;205:45-54. doi: 10.1016/j.puhe.2022.01.018. Epub 2022 Feb 26.
4
Co-administration of multiple intravenous medicines: Intensive care nurses' views and perspectives.静脉注射药物联合使用：重症监护护士的观点和看法。
Nurs Crit Care. 2020 May;25(3):156-164. doi: 10.1111/nicc.12497. Epub 2020 Jan 16.
5
Preparing and administering injectable antibiotics: How to avoid playing God.配制和使用注射用抗生素：如何避免扮演上帝。
Med Mal Infect. 2016 Jul;46(5):242-68. doi: 10.1016/j.medmal.2016.01.010. Epub 2016 Apr 21.
6
Stability of generic brands of meropenem reconstituted in isotonic saline.美罗培南在等渗盐水中复溶后的仿制药稳定性。
Minerva Anestesiol. 2015 Mar;81(3):283-7. Epub 2014 Sep 15.
7
PICC-associated bloodstream infections: prevalence, patterns, and predictors.经外周静脉置入中心静脉导管相关血流感染：发生率、类型和预测因素。
Am J Med. 2014 Apr;127(4):319-28. doi: 10.1016/j.amjmed.2014.01.001. Epub 2014 Jan 17.
8
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.严重脓毒症患者中β-内酰胺类抗生素持续输注：一项多中心、双盲、随机对照试验。
Clin Infect Dis. 2013 Jan;56(2):236-44. doi: 10.1093/cid/cis856. Epub 2012 Oct 16.
9
Stability of meropenem and doripenem solutions for administration by continuous infusion.美罗培南和多利培南持续输注溶液的稳定性。
J Antimicrob Chemother. 2010 May;65(5):1073-5. doi: 10.1093/jac/dkq044. Epub 2010 Feb 21.